AGM on July 16, 2026; FY26 revenue up 17% to Rs 5,453 cr, PAT crosses Rs 1,000 cr

Board & Shareholder Meetings View source PDF

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.4%1-day move

₹3060.00

prior close

₹3070.00

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.4+0.1-0.1+0.6+0.4+4.2+4.2+6.4+4.3+11.9+10.0+13.3——

Up moveDown movePending

AI summary

Ajanta Pharma filed FY26 annual report and AGM notice. 47th AGM on July 16, 2026 at 11:00 am via video conferencing. FY26 revenue grew 17% to Rs 5,453 cr, led by 49% jump in US Generics (Rs 1,557 cr) and 14% in India (Rs 1,654 cr). Adjusted EBITDA rose 18% to Rs 1,498 cr. PAT crossed Rs 1,000 cr milestone at Rs 1,056 cr, up 15%. EPS at Rs 85. Dividend payout of Rs 350 cr.

Likely market impact

Strong FY26 with revenue up 17% and PAT crossing Rs 1,000 cr. US business grew 49%. Positive for shareholders.